Physician profile
William B Jones
NPI 1407948284
$1,031.29
in general payments reported to CMS, 2019-2025
15 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $89.95 · 2021: $184 · 2022: $261 · 2023: $16.58 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $118.45 | 2019-2022 | |
| Stryker Corporation | $117.60 | 2025 | Clottriever Bold Catheter |
| Pfizer INC. | $107.09 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $102.11 | 2019 | |
| Lundbeck LLC | $97.50 | 2021 | |
| Novo Nordisk INC | $77.00 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.44 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.10 | 2021-2022 | |
| Lilly USA, LLC | $60.16 | 2020-2022 | |
| Allergan, INC. | $54.14 | 2019 | |
| Vifor Pharma, INC. | $45.64 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.06 | 2022 | |
| Janssen Pharmaceuticals, INC | $39.21 | 2019 | |
| Sunovion Pharmaceuticals INC. | $22.21 | 2019 | |
| Stemline Therapeutics INC. | $16.58 | 2023 | Orserdu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.